[Studies on anti-atherosclerotic agents. VII. Experimental studies of sodium chondroitin polysulfate on hypolipemic, anticoagulative, fibrinolytic and lipotropic activities].
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D001777:Blood Coagulation / Q000187:drug effects*; D002807:Chondroitin / Q000494:pharmacology*; D003911:Dextrans / Q000494:pharmacology; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D008055:Lipids / Q000097:blood*; D008082:Lipotropic Agents / Q000494:pharmacology*; D008297:Male; D051379:Mice; D051381:Rats; D013431:Sulfates / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
D003911:Dextrans; D008055:Lipids; D008082:Lipotropic Agents; D013431:Sulfates; D014280:Triglycerides; D002807:Chondroitin